US equity markets mixed, relinquishing earlier session gains as investors eye a pair of inflation reports later in the week - Dow added +29-points or +0.09%, paring an earlier rally of as much as +306-points. The broader S&P500 slipped -0.12%, with Information Technology (down -0.88%) the key drag and among four of the eleven primary sectors to settle in the red. Real Estate (up +0.70%) and Materials (+0.55%) both rose over >0.5%. The Nasdaq -0.10%. Nvidia Corp dropped -6.30% after the semiconductor company disclosed that it expects to fall well short of revenue expectations for its latest quarter, largely due to gaming weakness (with revenue for this sector expected to fall -33% from a year earlier to US$2.04B and versus consensus US$3.04B). The company expects fiscal second-quarter revenue of US$6.7B, up from US$6.5B a year earlier, but short of both current consensus analyst forecasts, and the chipmaker’s own forecast for US$8.1B. The company also anticipates US$3.81B in data-centre revenue, up +1% sequentially and 61% ahead of what the company posted a year earlier, but slightly below current consensus of US$3.99B. Executives noted that while the data-centre total marked a record, it came up “somewhat short of the company’s expectations, as it was impacted by supply chain disruptions.” Nvidia is slated to report its second quarter result on 24 August. The small capitalisation Russell 2000 outperformed with a +1.01% gain. In merger and acquisition (M&A) news, Global Blood Therapeutics gained +4.32% after Pfizer Inc (+0.61%) agreed to purchase the company that has one of the few approved treatments for sickle-cell disease for US$5.4B (US$68.50 per share). The acquisition continues a string of deals for Pfizer, which is flush with cash from sales of its COVID-19 vaccine and drug and which has said wants to add US$25B in revenue from business-development moves like M&A by 2030. Signify Health Inc jumped +10.97% following a report from The Wall Street Journal that CVS Health (down -0.25%) was planning to make a bid for the healthcare platform.